A cost-effectiveness analysis of preimplantation genetic testing for aneuploidy (PGT-A) for up to three complete assisted reproductive technology cycles in women of advanced maternal age

被引:23
作者
Lee, Evelyn [1 ]
Costello, Michael F. [2 ]
Botha, Willings C. [3 ]
Illingworth, Peter [4 ]
Chambers, Georgina M. [5 ]
机构
[1] Univ New South Wales, Ctr Social Res Hlth, Sydney, NSW, Australia
[2] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia
[3] Univ New South Wales, Ctr Big Data Res Hlth, Natl Perinatal Epidemiol & Stat, Sydney, NSW, Australia
[4] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia
[5] IVF Australia Pty Ltd, Sydney, NSW, Australia
关键词
aneuploidy; assisted reproductive technology; cost-effectiveness analysis; cumulative live-birth rate; preimplantation genetic diagnosis;
D O I
10.1111/ajo.12988
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background Current evidence suggests that preimplantation genetic testing for aneuploidy (PGT-A) used during assisted reproductive technology improves per-cycle live-birth rates but cumulative live-birth rate (CLBR) was similar to a strategy of morphological assessment (MA) of embryos. No study has assessed the cost-effectiveness of repeated cycles with PGT-A using longitudinal patient-level data. Aim To assess the cost-effectiveness of repeated cycles with PGT-A compared to MA of embryos in older women. Materials and Methods Micro-costing methods were used to value direct resource consumption of 2093 assisted reproductive technology-naive women aged >= 37 years undergoing up to three 'complete assisted reproductive technology cycles' (fresh plus cryopreserved embryos) with either PGT-A or MA in an Australian clinic between 2011 and 2014. Incremental cost-effective ratios were calculated from healthcare and patient perspectives with uncertainty assessed using non-parametric bootstrap methods. Cost-effectiveness acceptability curves were constructed to evaluate the probability of PGT-A being cost-effective over a range of willingness-to-pay thresholds. Results The CLBR and mean healthcare costs per patient were 30.90% and $22 962 for the PGT-A group, and 26.77% and $21 801 for the MA group, yielding an incremental cost-effective ratio of $28 103 for an additional live birth with PGT-A. At a willingness-to-pay threshold of $50 000 and above, there is more than an 80% probability of PGT-A being cost-effective from the healthcare perspective and a 50% likelihood from a patient perspective. Conclusion This is the first study to use real-world patient-level data to assess the cost-effectiveness of PGT-A in older women from the healthcare and patient perspectives. The findings contribute to the ongoing debate on the role of PGT-A in clinical practice.
引用
收藏
页码:573 / 579
页数:7
相关论文
共 30 条
  • [21] Preimplantation genetic screening: back to the future
    Mastenbroek, Sebastiaan
    Repping, Sjoerd
    [J]. HUMAN REPRODUCTION, 2014, 29 (09) : 1846 - 1850
  • [22] Medicare Australia, 2015, MBS ONL
  • [23] Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage
    Neal, Shelby A.
    Morin, Scott J.
    Franasiak, Jason M.
    Goodman, Linnea R.
    Juneau, Caroline R.
    Forman, Eric J.
    Werner, Marie D.
    Scott, Richard T., Jr.
    [J]. FERTILITY AND STERILITY, 2018, 110 (05) : 896 - 904
  • [24] A direct healthcare cost analysis of the cryopreserved versus fresh transfer policy at the blastocyst stage
    Papaleo, Enrico
    Pagliardini, Luca
    Vanni, Valeria Stella
    Delprato, Diana
    Rubino, Patrizia
    Candiani, Massimo
    Vigano, Paola
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2017, 34 (01) : 19 - 26
  • [25] Cost-Effectiveness of the Freeze-All Policy
    Roque, Matheus
    Valle, Marcello
    Guimaraes, Fernando
    Sampaio, Marcos
    Geber, Selmo
    [J]. JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2015, 19 (03): : 125 - 130
  • [26] Reliability and Validity of the Contingent Valuation Method for Estimating Willingness to Pay: A Case of In Vitro Fertilisation
    Settumba, Stella Nalukwago
    Shanahan, Marian
    Botha, Willings
    Ramli, Muhammad Zulilhaam
    Chambers, Georgina Mary
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2019, 17 (01) : 103 - 110
  • [27] Stankewicz T, 2017, FERTIL STERIL, V107, pE14
  • [28] Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial
    Verpoest, Willem
    Staessen, Catherine
    Bossuyt, Patrick M.
    Goossens, Veerle
    Altarescu, Gheona
    Bonduelle, Maryse
    Devesa, Martha
    Eldar-Geva, Talia
    Gianaroli, Luca
    Griesinger, Georg
    Kakourou, Georgia
    Kokkali, Georgia
    Liebenthron, Jana
    Magli, Maria-Cristina
    Parriego, Monica
    Schmutzler, Andreas G.
    Tobler, Monica
    van der Ven, Katrin
    Geraedts, Joep
    Sermon, Karen
    [J]. HUMAN REPRODUCTION, 2018, 33 (09) : 1767 - 1776
  • [29] Chromosomal mosaicism detected during preimplantation genetic screening: results of a worldwide Web-based survey
    Weissman, Ariel
    Shoham, Gon
    Shoham, Zeev
    Fishel, Simon
    Leong, Milton
    Yarona, Yuval
    [J]. FERTILITY AND STERILITY, 2017, 107 (05) : 1092 - 1097
  • [30] Limitations of Embryo Selection Methods
    Wong, Kai Mee
    Repping, Sjoerd
    Mastenbroek, Sebastiaan
    [J]. SEMINARS IN REPRODUCTIVE MEDICINE, 2014, 32 (02) : 127 - 133